Evotec SE (EVO) NASDAQ

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Christian Wojczewski	CEO & Chairperson of the Management Board	2.9M	1973
Ian Hunneyball	Senior Vice President of Programme Management & Clinical Operations	134,444	1950
Ingrid Mller	Chief Operating Officer & Member of Management Board	673,657	1972
Cord Dohrmann	Chief Scientific Officer & Member of Management Board	884,317	1964
Aurelie Dalbiez	Chief People Officer & Member of Management Board	1.11M	1977
Paul Hitchin	Chief Financial Officer & Member of Management Board	1.34M	1976
Claire Hinshelwood	Chief Financial Officer & Member of Management Board	1.34M	N/A
Sarah Fakih	Executive VP, Head of Global Communications & Investor Relations	0	N/A
Uwe Andag	EVP Head of Metabolic Diseases	0	N/A
Christiane Honisch	SVP Head of Diagnostics	0	N/A
David Hallet	Executive Vice President	0	N/A
Christian Dargel	EVice President Global Head of Legal & Compliance	0	1971

Name

Title

Pay

Year Born

Christian Wojczewski

CEO & Chairperson of the Management Board

2.9M

1973

Ian Hunneyball

Senior Vice President of Programme Management & Clinical Operations

134,444

1950

Ingrid Mller

Chief Operating Officer & Member of Management Board

673,657

1972

Cord Dohrmann

Chief Scientific Officer & Member of Management Board

884,317

1964

Aurelie Dalbiez

Chief People Officer & Member of Management Board

1.11M

1977

Paul Hitchin

Chief Financial Officer & Member of Management Board

1.34M

1976

Claire Hinshelwood

Chief Financial Officer & Member of Management Board

1.34M

N/A

Sarah Fakih

Executive VP, Head of Global Communications & Investor Relations

N/A

Uwe Andag

EVP Head of Metabolic Diseases

N/A

Christiane Honisch

SVP Head of Diagnostics

N/A

David Hallet

Executive Vice President

N/A

Christian Dargel

EVice President Global Head of Legal & Compliance

1971

Description

Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervous system (CNS) diseases, oncology, pain management, inflammatory ailments, immunological dysfunctions, rare diseases, respiratory conditions, and women's health. The company maintains strategic alliances and collaborations with numerous prominent organizations, including Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang JingXin Pharmaceutical Co., Ltd, Kazia Therapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. Established in 1993, the company was formerly known as Evotec AG, changing its name to Evotec SE in April 2019. Its corporate headquarters are located in Hamburg, Germany.